@article{a23ca08bcb544ec2a54b597ba96dcb10,
title = "Trends in use and expenditures of brand-name atorvastatin after introduction of generic atorvastatin",
author = "Warraich, {Haider J.} and Salami, {Joseph A.} and Rohan Khera and Javier Valero-Elizondo and Victor Okunrintemi and Khurram Nasir",
note = "Funding Information: Funding/Support: The data used in this analysis were obtained from The Dartmouth Atlas, which is funded by the Robert Wood Johnson Foundation and the Dartmouth Clinical and Translational Science Institute, under award No. UL1TR001086 from the National Center for Advancing Translational Sciences of the National Institutes of Health. Funding Information: Corresponding Author: Jing Luo, MD, MPH, Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women{\textquoteright}s Hospital, 1620 Tremont St, Ste 3030, Boston, MA 02120 (jluo1@bwh.harvard.org). Conflict of Interest Disclosures: None reported. Funding/Support: Dr Kesselheim{\textquoteright}s work is supported through a grant from the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science and the Engelberg Foundation. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.",
year = "2018",
month = may,
doi = "10.1001/jamainternmed.2018.0990",
language = "English (US)",
volume = "178",
pages = "719--721",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "5",
}